169 related articles for article (PubMed ID: 17657678)
21. [Relationship between macrophage migration inhibitory factor and cardiac function in patients with congestive heart failure].
Liu Y; Yu XY; Lin QX; Yang M; Shan ZX; Zheng M
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1169-70. PubMed ID: 14625178
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.
Kim HY; Lee HG; Kim DS
J Rheumatol; 2000 Mar; 27(3):801-6. PubMed ID: 10743828
[TBL] [Abstract][Full Text] [Related]
23. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
Zou YQ; Lu LJ; Li SJ; Zeng T; Wang XD; Bao CD; Chen SL; Yang CD
Clin Biochem; 2008 May; 41(7-8):519-24. PubMed ID: 18261992
[TBL] [Abstract][Full Text] [Related]
24. [Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease].
Matsubara T
Arerugi; 1991 Feb; 40(2):147-54. PubMed ID: 2069514
[TBL] [Abstract][Full Text] [Related]
25. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756
[TBL] [Abstract][Full Text] [Related]
26. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.
Matsumoto K; Maruyama N; Maruyama T; Ohnishi Y; Nonaka S; Inoshita A; Ito K; Kitajima S; Abe M; Satomura A; Fujita T
Clin Exp Immunol; 2005 Feb; 139(2):338-47. PubMed ID: 15654833
[TBL] [Abstract][Full Text] [Related]
27. Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF).
Joshi PC; Poole GV; Sachdev V; Zhou X; Jones Q
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):13-20. PubMed ID: 11334363
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis.
Morin M; Bellehumeur C; Therriault MJ; Metz C; Maheux R; Akoum A
Fertil Steril; 2005 Apr; 83(4):865-72. PubMed ID: 15820792
[TBL] [Abstract][Full Text] [Related]
29. Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF-173G/C polymorphism.
Rigante D; Flex A; Federico G; Pola R; Candelli M; Manna R; Pugliese AL; Cerquaglia C; Compagnone A; Stabile A
Scand J Rheumatol; 2007; 36(4):307-10. PubMed ID: 17763209
[TBL] [Abstract][Full Text] [Related]
30. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
Bargagli E; Olivieri C; Nikiforakis N; Cintorino M; Magi B; Perari MG; Vagaggini C; Spina D; Prasse A; Rottoli P
Respir Physiol Neurobiol; 2009 Jul; 167(3):261-7. PubMed ID: 19464392
[TBL] [Abstract][Full Text] [Related]
31. [The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome].
Guo Y; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):337-40. PubMed ID: 12126556
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor in cancer.
Yasasever V; Camlica H; Duranyildiz D; Oguz H; Tas F; Dalay N
Cancer Invest; 2007 Dec; 25(8):715-9. PubMed ID: 18058468
[TBL] [Abstract][Full Text] [Related]
33. Induction of macrophage migration inhibitory factor precedes the onset of acute tonsillitis.
Shimizu T; Niizeki H; Takeuchi O; Yamasaki Y; Inamoto N; Kusunoki Y; Kobayashi K; Abe R; Shimizu H; Nishikawa T; Hashiguchi K; Nishihira J
Mediators Inflamm; 2004 Aug; 13(4):293-5. PubMed ID: 15545061
[TBL] [Abstract][Full Text] [Related]
34. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
Emonts M; Sweep FC; Grebenchtchikov N; Geurts-Moespot A; Knaup M; Chanson AL; Erard V; Renner P; Hermans PW; Hazelzet JA; Calandra T
Clin Infect Dis; 2007 May; 44(10):1321-8. PubMed ID: 17443469
[TBL] [Abstract][Full Text] [Related]
35. Macrophage migration inhibitory factor in zinc-allergic systemic contact dermatitis.
Yanagi T; Kodama K; Yoshihisa Y; Shimizu H; Shimizu T
Cytokine; 2006 Sep; 35(5-6):270-4. PubMed ID: 17070066
[TBL] [Abstract][Full Text] [Related]
36. Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality.
Chuang CC; Wang ST; Chen WC; Chen CC; Hor LI; Chuang AY
Shock; 2007 May; 27(5):503-6. PubMed ID: 17438455
[TBL] [Abstract][Full Text] [Related]
37. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
[TBL] [Abstract][Full Text] [Related]
38. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.
Ueno Y; Takano N; Kanegane H; Yokoi T; Yachie A; Miyawaki T; Taniguchi N
Clin Exp Immunol; 1989 Jun; 76(3):337-42. PubMed ID: 2473858
[TBL] [Abstract][Full Text] [Related]
39. A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.
De Mast Q; Sweep FC; McCall M; Geurts-Moespot A; Hermsen C; Calandra T; Netea MG; Sauerwein RW; van der Ven AJ
Parasite Immunol; 2008 Mar; 30(3):133-8. PubMed ID: 18179626
[TBL] [Abstract][Full Text] [Related]
40. Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor.
Li S; Zhang R; Li P; Yi W; Zhang Z; Chen S; Su S; Zhao L; Hu C
Int Immunopharmacol; 2008 Jun; 8(6):859-65. PubMed ID: 18442790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
